$EG
EVEREST GROUP, LTD. Stock $eg

$eg Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000109507321000035 Filed on November 04, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q3
Revenue	$3.120B	$2.925B	$2.610B
YoY Change	1303.37%	12.08%	27.79%
Cost Of Revenue		$2.274B	$1.736B
YoY Change		30.99%	26.55%
Gross Profit		$651.1M	$874.0M
YoY Change		-25.5%	30.33%
Gross Profit Margin		22.26%	33.48%
Selling, General & Admin	$619.1M	$582.2M	$456.0M
YoY Change	17.93%	27.66%	1.0%
% of Gross Profit		89.41%	52.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$2.597B	$2.998B	$2.206B
YoY Change	1.8%	35.88%	13.62%
Operating Profit		-$2.346B	-$1.332B
YoY Change		76.15%	4.81%
Interest Expense	-$23.36M	-$15.54M	$6.641M
YoY Change	57.86%	-333.99%	-16.01%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$500.1M	-$87.72M	$272.5M
YoY Change	318.81%	-132.19%	192.96%
Income Tax	$69.36M	-$14.25M	$29.45M
% Of Pretax Income	13.87%		10.81%
Net Earnings	$430.7M	-$73.47M	$243.1M
YoY Change	577.2%	-130.23%	132.82%
Net Earnings / Revenue	13.8%	-2.51%	9.31%
Basic Earnings Per Share		-$1.88	$6.08
Diluted Earnings Per Share	$11.09M	-$1.876M	$6.07
COMMON SHARES
Basic Shares Outstanding	39.37M shares	39.16M shares	39.48M shares
Diluted Shares Outstanding		39.20M shares	39.56M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$1.441B	$1.068B	$938.9M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment			$149.0M
YoY Change			152.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.920B	$2.855B	$1.912B
YoY Change	45.09%	49.36%	11.4%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$38.19B	$36.61B	$30.15B
YoY Change	16.73%	21.4%	11.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$17.35M	$23.27M	$171.0M
YoY Change	-90.14%	-86.39%	134.25%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$34.05M	$111.0M	$291.0M
YoY Change	-91.11%	-61.87%	129.13%
LONG-TERM LIABILITIES
Long-Term Debt	$3.089B	$1.911B	$711.0M
YoY Change	61.71%	168.77%	12.15%
Other Long-Term Liabilities	$800.6M	$687.0M	$459.0M
YoY Change	53.66%	49.67%	43.89%
Total Long-Term Liabilities	$3.889B	$2.598B	$1.170B
YoY Change	59.98%	122.05%	22.77%
TOTAL LIABILITIES
Total Short-Term Liabilities	$34.05M	$111.0M	$291.0M
Total Long-Term Liabilities	$3.889B	$2.598B	$1.170B
Total Liabilities	$28.05B	$26.63B	$20.56B
YoY Change	22.02%	29.5%	13.98%
SHAREHOLDERS EQUITY
Retained Earnings	$11.70B	$11.33B	$10.57B
YoY Change	10.72%	7.23%	4.07%
Common Stock	$698.0K	$698.0K	$696.0K
YoY Change	0.29%	0.29%	0.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.847B	$3.822B	$3.622B
YoY Change	6.22%	5.52%	5.84%
Treasury Stock Shares	30.52M shares	30.43M shares	29.64M shares
Shareholders Equity	$10.14B	$9.979B	$9.591B
YoY Change
Total Liabilities & Shareholders Equity	$38.19B	$36.61B	$30.15B
YoY Change	16.73%	21.4%	11.58%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	$430.7M	-$73.47M	$243.1M
YoY Change	577.2%	-130.23%	132.82%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$1.043B	$1.163B	$1.086B
YoY Change	52.68%	7.05%	71.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$1.767B	-$969.1M	-$1.100B
YoY Change	-9.56%	-11.92%	111.03%
Cash From Investing Activities	-$1.767B	-$969.1M	-$1.100B
YoY Change	-9.56%	-11.92%	111.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.087B	-223.4M	26.20M
YoY Change	-4.36%	-952.75%	-145.17%
NET CHANGE
Cash From Operating Activities	1.043B	1.163B	1.086B
Cash From Investing Activities	-1.767B	-969.1M	-1.100B
Cash From Financing Activities	1.087B	-223.4M	26.20M
Net Change In Cash	362.8M	-29.97M	11.90M
YoY Change	-370.36%	-351.83%	-77.96%
FREE CASH FLOW
Cash From Operating Activities	$1.043B	$1.163B	$1.086B
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q3	us-gaap	Income Tax Receivable IncomeTaxReceivable		USD
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
	re	Assumed Losses And Loss Adjustment Expenses AssumedLossesAndLossAdjustmentExpenses		USD
	re	Assumed Losses And Loss Adjustment Expenses AssumedLossesAndLossAdjustmentExpenses		USD
	re	Contractual Commitments Investment Period Expiration Date ContractualCommitmentsInvestmentPeriodExpirationDate	2026-12-31
	dei	Entity Address Address Line1 EntityAddressAddressLine1	Seon Place – 4th Floor
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2020Q4	re	Other Short Term Investments Cost OtherShortTermInvestmentsCost	1135088000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	19225067000	USD
CY2020Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	1134950000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2012581000	USD
CY2020Q4	us-gaap	Cash Cash	801651000	USD
CY2020Q4	us-gaap	Investments And Cash InvestmentsAndCash	25461591000	USD
CY2020Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	141304000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	1994555000	USD
CY2020Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	622053000	USD
CY2020Q4	us-gaap	Prepaid Reinsurance Premiums PrepaidReinsurancePremiums	412015000	USD
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D0
	dei	Entity Central Index Key EntityCentralIndexKey	0001095073
CY2021Q3	re	Other Short Term Investments Cost OtherShortTermInvestmentsCost	713144000	USD
CY2021Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	713144000	USD
CY2021Q3	us-gaap	Equity Method Investments EquityMethodInvestments	2855372000	USD
CY2021Q3	us-gaap	Cash Cash	1068441000	USD
CY2021Q3	us-gaap	Investments And Cash InvestmentsAndCash	27783671000	USD
CY2021Q3	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	170364000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt		USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss		USD
CY2020Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent		USD
CY2021Q3	re	Assumed Losses And Loss Adjustment Expenses AssumedLossesAndLossAdjustmentExpenses		USD
CY2020Q3	re	Assumed Losses And Loss Adjustment Expenses AssumedLossesAndLossAdjustmentExpenses		USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal		USD
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal		USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt		USD
	re	Proceeds From Payments For Fhlbank Advance ProceedsFromPaymentsForFhlbankAdvance		USD
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-15731
	dei	Entity Registrant Name EntityRegistrantName	EVEREST RE GROUP, LTD.
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0365432
	dei	Entity Address Address Line2 EntityAddressAddressLine2	141 Front Street
	dei	Entity Address Address Line3 EntityAddressAddressLine3	PO Box HM 845
	dei	Entity Address City Or Town EntityAddressCityOrTown	Hamilton
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	HM 19
	dei	Entity Address Country EntityAddressCountry	BM
	dei	City Area Code CityAreaCode	441
	dei	Local Phone Number LocalPhoneNumber	295-0006
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Shares, $0.01 par value
	dei	Trading Symbol TradingSymbol	RE
	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	39369026	shares
CY2021Q3	re	Available For Sale Securities Debt Securities Market Value AvailableForSaleSecuritiesDebtSecuritiesMarketValue	21623119000	USD
CY2020Q4	re	Available For Sale Securities Debt Securities Market Value AvailableForSaleSecuritiesDebtSecuritiesMarketValue	20040173000	USD
CY2021Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	21182756000	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	31980000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	1745000	USD
CY2021Q3	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1523595000	USD
CY2020Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1472236000	USD
CY2021Q3	us-gaap	Premiums Receivable At Carrying Value PremiumsReceivableAtCarryingValue	3408338000	USD
CY2020Q4	us-gaap	Premiums Receivable At Carrying Value PremiumsReceivableAtCarryingValue	2680562000	USD
CY2021Q3	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	2215380000	USD
CY2021Q3	us-gaap	Funds Held Under Reinsurance Agreements Asset FundsHeldUnderReinsuranceAgreementsAsset	811269000	USD
CY2020Q4	us-gaap	Funds Held Under Reinsurance Agreements Asset FundsHeldUnderReinsuranceAgreementsAsset	716655000	USD
CY2020Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	110203000	USD
CY2021Q3	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	797735000	USD
CY2021Q3	us-gaap	Prepaid Reinsurance Premiums PrepaidReinsurancePremiums	552468000	USD
CY2020Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	17253000	USD
CY2021Q3	us-gaap	Other Assets OtherAssets	866872000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	742369000	USD
CY2021Q3	us-gaap	Assets Assets	36606097000	USD
CY2020Q4	us-gaap	Assets Assets	32788357000	USD
CY2021Q3	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	18956953000	USD
CY2020Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	16398997000	USD
CY2021Q3	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	36533000	USD
CY2020Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	37723000	USD
CY2021Q3	us-gaap	Unearned Premiums UnearnedPremiums	4421098000	USD
CY2020Q4	us-gaap	Unearned Premiums UnearnedPremiums	3501359000	USD
CY2021Q3	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	18279000	USD
CY2020Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	15807000	USD
CY2021Q3	us-gaap	Reinsurance Payable ReinsurancePayable	485682000	USD
CY2020Q4	us-gaap	Reinsurance Payable ReinsurancePayable	294347000	USD
CY2021Q3	re	Loss In Course Of Payment LossInCourseOfPayment	150784000	USD
CY2020Q4	re	Loss In Course Of Payment LossInCourseOfPayment	127971000	USD
CY2021Q3	us-gaap	Subordinated Debt SubordinatedDebt	223749000	USD
CY2020Q4	us-gaap	Subordinated Debt SubordinatedDebt	223674000	USD
CY2021Q3	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	310000000	USD
CY2020Q4	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	310000000	USD
CY2021Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	23267000	USD
CY2020Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	10460000	USD
CY2021Q3	us-gaap	Other Payables To Broker Dealers And Clearing Organizations OtherPayablesToBrokerDealersAndClearingOrganizations	83626000	USD
CY2020Q4	us-gaap	Other Payables To Broker Dealers And Clearing Organizations OtherPayablesToBrokerDealersAndClearingOrganizations	206693000	USD
CY2021Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	4074000	USD
CY2021Q3	us-gaap	Other Liabilities OtherLiabilities	536218000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	558432000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	26627462000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	23062181000	USD
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	69806000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	69620000	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	698000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	696000	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2266342000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2245301000	USD
	re	Accumulated Other Comprehensive Income Loss Tax AccumulatedOtherComprehensiveIncomeLossTax	44338000	USD
CY2020	re	Accumulated Other Comprehensive Income Loss Tax AccumulatedOtherComprehensiveIncomeLossTax	80451000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	203733000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	534899000	USD
CY2021Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	30427000	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	29636000	shares
CY2021Q3	us-gaap	Treasury Stock Value TreasuryStockValue	3822235000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3622172000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11330097000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	10567452000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	9978635000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	9726176000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	36606097000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32788357000	USD
CY2021Q3	us-gaap	Premiums Earned Net PremiumsEarnedNet	2656403000	USD
CY2020Q3	us-gaap	Premiums Earned Net PremiumsEarnedNet	2205811000	USD
	us-gaap	Net Investment Income NetInvestmentIncome	960267000	USD
	us-gaap	Net Investment Income NetInvestmentIncome	420116000	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment	-7329000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment	6196000	USD
	us-gaap	Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment	-30234000	USD
	us-gaap	Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment	-19641000	USD
CY2021Q3	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	3107000	USD
CY2020Q3	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	104007000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	138789000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	84263000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	44190000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	47306000	USD
CY2021Q3	us-gaap	Revenues Revenues	2925423000	USD
CY2020Q3	us-gaap	Revenues Revenues	2610184000	USD
CY2021Q3	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	2274301000	USD
CY2020Q3	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1736210000	USD
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	564335000	USD
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	445332000	USD
CY2021Q3	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	141150000	USD
CY2020Q3	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	138875000	USD
CY2021Q3	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	3013142000	USD
	re	Corporate Expenses CorporateExpenses	46363000	USD
	re	Corporate Expenses CorporateExpenses	29184000	USD
CY2021Q3	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	15539000	USD
CY2020Q3	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	6641000	USD
	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	46785000	USD
	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	21477000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	11.18
CY2020Q3	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2337676000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1045557000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	465953000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-14251000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29451000	USD
	us-gaap	Profit Loss ProfitLoss	948376000	USD
	us-gaap	Profit Loss ProfitLoss	450549000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-100021000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	63480000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	1388000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	11453000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-307929000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	348524000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-53599000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	60628000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax	-1563000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax	-1806000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-1563000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-1806000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-331166000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	383446000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-226913000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	357518000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	23.74
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	11.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	23.72
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.55
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.55
CY2021Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.55
CY2020Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.55
CY2021Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.55
CY2020Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.55
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	9978635000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	9591292000	USD
	us-gaap	Profit Loss ProfitLoss	948376000	USD
	us-gaap	Profit Loss ProfitLoss	450549000	USD
	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	736614000	USD
	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	357162000	USD
	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	92512000	USD
	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	53878000	USD
	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	230593000	USD
	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	172454000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-57270000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-184311000	USD
	us-gaap	Increase Decrease In Prepaid Reinsurance Premiums IncreaseDecreaseInPrepaidReinsurancePremiums	146639000	USD
	us-gaap	Increase Decrease In Prepaid Reinsurance Premiums IncreaseDecreaseInPrepaidReinsurancePremiums	7963000	USD
	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	2576049000	USD
	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	1665982000	USD
	us-gaap	Increase Decrease In Future Policy Benefit Reserves IncreaseDecreaseInFuturePolicyBenefitReserves	-1189000	USD
	us-gaap	Increase Decrease In Future Policy Benefit Reserves IncreaseDecreaseInFuturePolicyBenefitReserves	-2218000	USD
	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	927524000	USD
	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	392904000	USD
	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	198954000	USD
	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	68784000	USD
	re	Increase Decrease In Losses In Course Of Payment IncreaseDecreaseInLossesInCourseOfPayment	23661000	USD
	re	Increase Decrease In Losses In Course Of Payment IncreaseDecreaseInLossesInCourseOfPayment	132208000	USD
	re	Change In Equity Adjustments In Limited Partnerships ChangeInEquityAdjustmentsInLimitedPartnerships	543401000	USD
	re	Change In Equity Adjustments In Limited Partnerships ChangeInEquityAdjustmentsInLimitedPartnerships	12475000	USD
	us-gaap	Reimbursement From Limited Partnership Investment ReimbursementFromLimitedPartnershipInvestment	105571000	USD
	us-gaap	Reimbursement From Limited Partnership Investment ReimbursementFromLimitedPartnershipInvestment	55576000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	247615000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	131224000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	33199000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	29337000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	57289000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	32594000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	138789000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	84263000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2790541000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2190608000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	2756963000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	1781821000	USD
	re	Proceeds From Sale Of Available For Sale Securities Debt Market Value ProceedsFromSaleOfAvailableForSaleSecuritiesDebtMarketValue	883149000	USD
	re	Proceeds From Sale Of Available For Sale Securities Debt Market Value ProceedsFromSaleOfAvailableForSaleSecuritiesDebtMarketValue	1390747000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2054000	USD
	re	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	578894000	USD
	re	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	329750000	USD
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	216573000	USD
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	210527000	USD
	re	Payments To Acquire Available For Sale Securities Debt Market Value PaymentsToAcquireAvailableForSaleSecuritiesDebtMarketValue	5670636000	USD
	re	Payments To Acquire Available For Sale Securities Debt Market Value PaymentsToAcquireAvailableForSaleSecuritiesDebtMarketValue	3874890000	USD
	re	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	507862000	USD
	re	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	460953000	USD
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	604180000	USD
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	392650000	USD
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-422643000	USD
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	804744000	USD
	re	Net Change In Unsettled Securities Transactions NetChangeInUnsettledSecuritiesTransactions	177259000	USD
	re	Net Change In Unsettled Securities Transactions NetChangeInUnsettledSecuritiesTransactions	-89064000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2101715000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1729274000	USD
	re	Payments For Shares Issued For Share Based Compensation Net Of Expense PaymentsForSharesIssuedForShareBasedCompensationNetOfExpense	12156000	USD
	re	Payments For Shares Issued For Share Based Compensation Net Of Expense PaymentsForSharesIssuedForShareBasedCompensationNetOfExpense	13617000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	200064000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	200020000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	185731000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	187110000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	10647000	USD
	re	Proceeds From Payments For Fhlbank Advance ProceedsFromPaymentsForFhlbankAdvance	90000000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	15133000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	15298000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-413084000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-336691000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-8952000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6203000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	266790000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	130845000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	801651000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	808036000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1068441000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	938881000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	39767000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-169149000	USD
	us-gaap	Interest Paid Net InterestPaidNet	33422000	USD
	us-gaap	Interest Paid Net InterestPaidNet	16731000	USD
	us-gaap	Nature Of Operations NatureOfOperations	<p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-weight: bold; font-size: 10.00pt">1. GENERAL</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">Everest Re Group, Ltd. (“Group”), a Bermuda company, through its subsidiaries, principally provides reinsurance and insurance in the U.S., Bermuda and international markets. As used in this document, “Company” means Group and its subsidiaries.</span></p>
	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-weight: bold; font-size: 10.00pt">2. BASIS OF PRESENTATION</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">The unaudited consolidated financial statements of the Company as of September 30, 2021 and December 31, 2020 and for the three and nine months ended September 30, 2021 and 2020 include all adjustments, consisting of normal recurring accruals, which, in the opinion of management, are necessary for a fair statement of the results on an interim basis. Certain financial information, which is normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), has been omitted since it is not required for interim reporting purposes. The December 31, 2020 consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. The results for the three and nine months ended September 30, 2021 and 2020 are not necessarily indicative of the results for a full year. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the years ended December 31, 2020, 2019 and 2018, included in the Company’s most recent Form 10-K filing.</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">The Company consolidates the results of operations and financial position of all voting interest entities ("VOE") in which the Company has a controlling financial interest and all variable interest entities ("VIE") in which the Company is considered to be the primary beneficiary. The consolidation assessment, including the determination as to whether an entity qualifies as a VIE or VOE, depends on the facts and circumstances surrounding each entity. </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities (and disclosure of contingent assets and liabilities) at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Ultimate actual results could differ, possibly materially, from those estimates. This is particularly true given the fluid and continuing nature of the COVID-19 Pandemic. This is an ongoing event and so is the Company’s evaluation and analysis. While the Company’s analysis considers all aspects of its operations, it does not take into account legal, regulatory or legislative intervention that could retroactively mandate or expand coverage provisions. Given the uncertainties in the current public health and economic environment, there could be an adverse impact on results for the Property & Casualty industry and the Company for the remainder of the year. The impact is dependent on the shape and length of the economic recovery.</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">All intercompany accounts and transactions have been eliminated. </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">Certain reclassifications and format changes have been made to prior years’ amounts to conform to the 2021 presentation.</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt; text-decoration: underline">Application of Recently Issued Accounting Standard Changes. </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-style: italic; font-size: 10.00pt">Reference Rate Reform - LIBOR.</span><span style="font-family: Calibri; font-size: 10.00pt"> In March 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-04 (and subsequently issued ASU 2021-01 in January 2021), which outlines the issues surrounding the cessation of LIBOR as a reference rate for contractual debt agreements. The guidance also details the potential alternative expedients and sources available for use in determination of rates and terms for such debt agreements in order to apply appropriate accounting policy. The guidance is effective for annual reporting</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">periods beginning after December 15, 2021. The Company is currently evaluating the impact of the adoption of ASU 2020-04 and 2021-01 on its financial statements.</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-style: italic; font-size: 10.00pt">Accounting for Income Taxes.</span><span style="font-family: Calibri; font-size: 10.00pt"> In December 2019, The FASB issued ASU 2019-12, which provides simplification of existing guidance for income taxes, including the removal of certain exceptions related to recognition of deferred tax liabilities on foreign subsidiaries. The guidance is effective for annual reporting periods beginning after December 15, 2020 and interim periods within that annual reporting period. The Company adopted the guidance as of January 1, 2021. The adoption of ASU 2019-12 did not have a material impact on the Company’s financial statements.</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-style: italic; font-size: 10.00pt">Accounting for Long Duration Contracts.</span><span style="font-family: Calibri; font-size: 10.00pt"> In August 2018, FASB issued ASU 2018-12, which discusses changes to the recognition, measurement and presentation of long duration contracts. The main provisions of this guidance address the following: 1) In determining liability for future policy benefits, companies must review cash flow assumptions at least annually and the discount rate assumption at each reporting period date 2) Amortization of deferred acquisition costs has been simplified to be in constant level proportion to either premiums, gross profits or gross margins 3) Disaggregated roll forwards of beginning and ending liabilities for future policy benefits are required. The guidance was originally effective for annual reporting periods beginning after December 15, 2020 and interim periods within that annual reporting period. However, FASB issued ASU 2019-09 in November 2019 and then ASU 2020-11 in November 2021, which ultimately defers the effective date of ASU 2018-12 until annual reporting periods beginning after December 15, 2022. The Company is currently evaluating the impact of the adoption of ASU 2018-12 on its financial statements.</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">Any issued guidance and pronouncements, other than those directly referenced above, are deemed by the Company to be either not applicable or immaterial to its financial statements.</span></p>
CY2021Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	21182756000	USD
CY2021Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	21182756000	USD
CY2021Q3	re	Available For Sale Securities Debt Securities Market Value AvailableForSaleSecuritiesDebtSecuritiesMarketValue	21623119000	USD
CY2020Q4	re	Available For Sale Securities Debt Securities Market Value AvailableForSaleSecuritiesDebtSecuritiesMarketValue	20040173000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-108789000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	55587000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-344370000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	392640000	USD
CY2021Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7380000	USD
CY2020Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3560000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-36441000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	44116000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-307929000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	348524000	USD
	re	Future Policy Benefit Reserve Income Expense FuturePolicyBenefitReserveIncomeExpense	-733000	USD
	re	Future Policy Benefit Reserve Income Expense FuturePolicyBenefitReserveIncomeExpense	-805000	USD
CY2021Q3	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	308609000	USD
CY2020Q3	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	244913000	USD
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1004036000	USD
CY2021Q3	re	Gross Investment Income Before Adjustment GrossInvestmentIncomeBeforeAdjustment	307685000	USD
CY2020Q3	re	Gross Investment Income Before Adjustment GrossInvestmentIncomeBeforeAdjustment	244520000	USD
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	454804000	USD
CY2021Q3	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	15850000	USD
CY2020Q3	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	10680000	USD
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	43769000	USD
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	34688000	USD
CY2021Q3	us-gaap	Investment Income Net InvestmentIncomeNet	292759000	USD
CY2020Q3	us-gaap	Investment Income Net InvestmentIncomeNet	234233000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	960267000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	420116000	USD
CY2021Q3	re	Additional Contractual Commitments AdditionalContractualCommitments	2648100000	USD
	re	Gross Investment Income Before Adjustment GrossInvestmentIncomeBeforeAdjustment	992320000	USD
	re	Gross Investment Income Before Adjustment GrossInvestmentIncomeBeforeAdjustment	444688000	USD
CY2021Q3	re	Funds Held Interest Income Expense FundsHeldInterestIncomeExpense	1196000	USD
CY2020Q3	re	Funds Held Interest Income Expense FundsHeldInterestIncomeExpense	684000	USD
	re	Funds Held Interest Income Expense FundsHeldInterestIncomeExpense	12449000	USD
	re	Funds Held Interest Income Expense FundsHeldInterestIncomeExpense	10921000	USD
CY2021Q3	re	Future Policy Benefit Reserve Income Expense FuturePolicyBenefitReserveIncomeExpense	-272000	USD
CY2020Q3	re	Future Policy Benefit Reserve Income Expense FuturePolicyBenefitReserveIncomeExpense	-291000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	138789000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	84263000	USD
CY2021Q2	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	24650000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	1745000	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	5408000	USD
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	27298000	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	3384000	USD
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	4852000	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold	-1462000	USD
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold	-1915000	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	31980000	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	31980000	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	25837000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	150000	USD
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	32884000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	5562000	USD
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	6644000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	-310000	USD
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	-4646000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold	-11598000	USD
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold	-15241000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	19641000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	19641000	USD
	us-gaap	Profit Loss ProfitLoss	948376000	USD
	us-gaap	Profit Loss ProfitLoss	450549000	USD
CY2021Q3	us-gaap	Dividends Common Stock DividendsCommonStock	61457000	USD
CY2020Q3	us-gaap	Dividends Common Stock DividendsCommonStock	61910000	USD
	us-gaap	Dividends Common Stock DividendsCommonStock	185731000	USD
	us-gaap	Dividends Common Stock DividendsCommonStock	187115000	USD
CY2020Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	16398997000	USD
CY2019Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	13611313000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	1843691000	USD
CY2020Q4	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	14555306000	USD
CY2019Q4	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	11970601000	USD
	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	5577911000	USD
	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	4572640000	USD
	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-6050000	USD
	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	1426000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	5571861000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	4574066000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	1375665000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	1015538000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	1786393000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	2042712000	USD
	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	3162058000	USD
	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	3058250000	USD
	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease	-41000000	USD
	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease	-28024000	USD
CY2021Q3	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	16924109000	USD
CY2020Q3	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	13458393000	USD
CY2021Q3	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	2032844000	USD
CY2020Q3	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	1774732000	USD
CY2021Q3	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	18956953000	USD
CY2020Q3	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	15233125000	USD
	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	5577900000	USD
	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	4572600000	USD
CY2021Q3	re	Public Equity Portfolio Fair Value Disclosure PublicEquityPortfolioFairValueDisclosure	1253900000	USD
CY2020Q4	re	Public Equity Portfolio Fair Value Disclosure PublicEquityPortfolioFairValueDisclosure	784700000	USD
CY2021Q3	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1523595000	USD
CY2020Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1472236000	USD
CY2021Q3	us-gaap	Undistributed Earnings UndistributedEarnings	-134925000	USD
CY2020Q3	us-gaap	Undistributed Earnings UndistributedEarnings	181148000	USD
	us-gaap	Undistributed Earnings UndistributedEarnings	762646000	USD
	us-gaap	Undistributed Earnings UndistributedEarnings	263435000	USD
CY2021Q3	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	1.000	pure
CY2020Q3	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.988	pure
	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.987	pure
	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.987	pure
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-134925000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	178938000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	752414000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	260096000	USD
CY2021Q3	re	Dividend Declared Common Shareholders DividendDeclaredCommonShareholders	61457000	USD
CY2020Q3	re	Dividend Declared Common Shareholders DividendDeclaredCommonShareholders	61199000	USD
	re	Dividend Declared Common Shareholders DividendDeclaredCommonShareholders	183333000	USD
	re	Dividend Declared Common Shareholders DividendDeclaredCommonShareholders	184836000	USD
CY2021Q3	re	Numerator For Basic And Diluted Earnings Per Common Share NumeratorForBasicAndDilutedEarningsPerCommonShare	-73468000	USD
CY2020Q3	re	Numerator For Basic And Diluted Earnings Per Common Share NumeratorForBasicAndDilutedEarningsPerCommonShare	240138000	USD
	re	Numerator For Basic And Diluted Earnings Per Common Share NumeratorForBasicAndDilutedEarningsPerCommonShare	935748000	USD
	re	Numerator For Basic And Diluted Earnings Per Common Share NumeratorForBasicAndDilutedEarningsPerCommonShare	444931000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	39161000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	39483000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	39409000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	39711000	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	36000	shares
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	74000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	44000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	79000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39197000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39557000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39452000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39790000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	23.74
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	11.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	23.72
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	11.18
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39161000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39483000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39409000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39711000	shares
CY2021Q3	re	Basic Weighted Average Common Shares Outstanding And Nonvested Common Shares Expected To Vest BasicWeightedAverageCommonSharesOutstandingAndNonvestedCommonSharesExpectedToVest	39161000	shares
CY2020Q3	re	Basic Weighted Average Common Shares Outstanding And Nonvested Common Shares Expected To Vest BasicWeightedAverageCommonSharesOutstandingAndNonvestedCommonSharesExpectedToVest	39971000	shares
	re	Basic Weighted Average Common Shares Outstanding And Nonvested Common Shares Expected To Vest BasicWeightedAverageCommonSharesOutstandingAndNonvestedCommonSharesExpectedToVest	39945000	shares
	re	Basic Weighted Average Common Shares Outstanding And Nonvested Common Shares Expected To Vest BasicWeightedAverageCommonSharesOutstandingAndNonvestedCommonSharesExpectedToVest	40221000	shares
CY2021Q3	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	1.000	pure
CY2020Q3	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.988	pure
	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.987	pure
	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.987	pure
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-367279000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-36113000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-331166000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	122324000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	7863000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	426931000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	43485000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	383446000	USD
CY2021Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1530000000.0	USD
CY2021Q3	re	Line Of Credit Facility Uncommited Amount Available LineOfCreditFacilityUncommitedAmountAvailable	140000000.0	USD
CY2021Q3	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	281000	USD
CY2020Q3	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	132000	USD
	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	1002000	USD
	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	587000	USD
CY2021Q3	re	Federal Home Loan Bank Advances General Debt Obligations Disclosures Maximum Percentage Of Admitted Assets Allowed For Borrowing Base FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumPercentageOfAdmittedAssetsAllowedForBorrowingBase	0.10	pure
CY2021Q3	us-gaap	Security Deposit SecurityDeposit	1526100000	USD
CY2021Q3	us-gaap	Ceded Premiums Written CededPremiumsWritten	114694000	USD
CY2020Q3	us-gaap	Ceded Premiums Written CededPremiumsWritten	86712000	USD
	us-gaap	Ceded Premiums Written CededPremiumsWritten	269987000	USD
	us-gaap	Ceded Premiums Written CededPremiumsWritten	245422000	USD
CY2021Q3	re	Ceded Earned Premiums CededEarnedPremiums	100133000	USD
CY2020Q3	re	Ceded Earned Premiums CededEarnedPremiums	71396000	USD
	re	Ceded Earned Premiums CededEarnedPremiums	249662000	USD
	re	Ceded Earned Premiums CededEarnedPremiums	233089000	USD
CY2021Q3	re	Ceded Losses And Loss Adjustment Expenses CededLossesAndLossAdjustmentExpenses	169998000	USD
CY2020Q3	re	Ceded Losses And Loss Adjustment Expenses CededLossesAndLossAdjustmentExpenses	87917000	USD
	re	Ceded Losses And Loss Adjustment Expenses CededLossesAndLossAdjustmentExpenses	281893000	USD
	re	Ceded Losses And Loss Adjustment Expenses CededLossesAndLossAdjustmentExpenses	173968000	USD
CY2021Q3	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	4273000	USD
CY2020Q3	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	8894000	USD
	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	9490000	USD
	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	14448000	USD
CY2021Q3	re	Assumed Earned Premiums AssumedEarnedPremiums	4273000	USD
CY2021Q3	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	-323383000	USD
CY2020Q3	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	-114606000	USD
	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	-4541000	USD
	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	-35071000	USD
	us-gaap	Net Investment Income NetInvestmentIncome	960267000	USD
	us-gaap	Net Investment Income NetInvestmentIncome	420116000	USD
CY2021Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-4222000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	138789000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	84263000	USD
	re	Corporate Expenses CorporateExpenses	46363000	USD
	re	Corporate Expenses CorporateExpenses	29184000	USD
CY2021Q3	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	15539000	USD
CY2020Q3	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	6641000	USD
	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	46785000	USD
	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	21477000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	44190000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	47306000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1045557000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	465953000	USD
	re	Percentage Threshold Of Company Revenue Not Exceeded By Any Other Country PercentageThresholdOfCompanyRevenueNotExceededByAnyOtherCountry	0.05	pure
	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	4378000	USD
	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	6126000	USD
CY2020Q3	re	Assumed Earned Premiums AssumedEarnedPremiums	8894000	USD
	re	Assumed Earned Premiums AssumedEarnedPremiums	9490000	USD
	re	Assumed Earned Premiums AssumedEarnedPremiums	14448000	USD
CY2021Q3	us-gaap	Reinsurance Recoverables Gross ReinsuranceRecoverablesGross	217500000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables Gross ReinsuranceRecoverablesGross	254900000	USD
CY2021Q3	re	Reinsurance Deferred Gain Liability ReinsuranceDeferredGainLiability	34400000	USD
CY2020Q4	re	Reinsurance Deferred Gain Liability ReinsuranceDeferredGainLiability	38800000	USD
	us-gaap	Debt Instrument Redemption Period End Date DebtInstrumentRedemptionPeriodEndDate	2047-05-01
CY2021Q3	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	1456000	USD
CY2020Q3	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	1587000	USD

Files In Submission

Name	View Source	Status
0001095073-21-000035-index-headers.html	Edgar Link	pending
0001095073-21-000035-index.html	Edgar Link	pending
0001095073-21-000035.txt	Edgar Link	pending
0001095073-21-000035-xbrl.zip	Edgar Link	pending
exhibit101.htm	Edgar Link	pending
exhibit102.htm	Edgar Link	pending
exhibit311.htm	Edgar Link	pending
exhibit312.htm	Edgar Link	pending
exhibit321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
re-20210930.htm	Edgar Link	pending
re-20210930.xsd	Edgar Link	pending
re-20210930_cal.xml	Edgar Link	unprocessable
re-20210930_def.xml	Edgar Link	unprocessable
re-20210930_htm.xml	Edgar Link	completed
re-20210930_lab.xml	Edgar Link	unprocessable
re-20210930_pre.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
x8173x0.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EG
EVEREST GROUP, LTD. Stock $eg

2021 Q4 Form 10-Q Financial Statement

#000109507321000035 Filed on November 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EG EVEREST GROUP, LTD. Stock $eg

2021 Q4 Form 10-Q Financial Statement

#000109507321000035 Filed on November 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EG
EVEREST GROUP, LTD. Stock $eg